Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 8, 2025Journal of Medical BiochemistryOpen Access

The Serum Damine oxidase (DAO), serum bacterial endotoxin (BT) and D-lactic acid (D-Lac) TNF-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in patients sepsis combined with acute kidney injury after Bexira administration

View Full Paper
Ask AI
Bookmark
Share

Authors

HHH. H. HUANG

Discussion

Loading...

Member takes

Overview

Randomized trial shows Bexira enhances immune response and reduces biomarkers in acute kidney injury patients with sepsis.

Key Points

  • Significant reductions in DAO, BT, and D-Lac levels were observed after treatment, indicating improved outcomes.
  • Patients receiving Bexira showed notably better results than those with conventional care, with P<0.05 confirming statistical significance.
  • The randomized study design increases the reliability of results, supporting the potential effectiveness of Bexira in treatment strategies.
  • Further research is warranted to explore the long-term benefits and pharmacological mechanisms behind Bexira's effects on patient recovery.

Cite This Study

H. H. HUANG (2025) studied this question.

synapsesocial.com/papers/68e5c1ba6950a706b22b520ehttps://doi.org/10.5937/jomb0-56191
View Full Paper
Ask AI
Bookmark
Share